Literature DB >> 6412935

Pulmonary hypertension in systemic lupus erythematosus.

R A Asherson, C G Mackworth-Young, M L Boey, R G Hull, A Saunders, A E Gharavi, G R Hughes.   

Abstract

Entities:  

Mesh:

Year:  1983        PMID: 6412935      PMCID: PMC1549591          DOI: 10.1136/bmj.287.6398.1024-a

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  4 in total

1.  Primary pulmonary hypertension. Review of clinical features and pathologic physiology with a report of pulmonary hemodynamics derived from repeated catheterization.

Authors:  J C SLEEPER; E S ORGAIN; H D McINTOSH
Journal:  Circulation       Date:  1962-12       Impact factor: 29.690

2.  Primary pulmonary hypertension.

Authors:  G Walcott; H B Burchell; A L Brown
Journal:  Am J Med       Date:  1970-07       Impact factor: 4.965

3.  Thrombosis in patients with the lupus anticoagulant.

Authors:  J R Mueh; K D Herbst; S I Rapaport
Journal:  Ann Intern Med       Date:  1980-02       Impact factor: 25.391

Review 4.  Pulmonary hypertension in systemic lupus erythematosus: report of four cases and review of the literature.

Authors:  H D Perez; N Kramer
Journal:  Semin Arthritis Rheum       Date:  1981-08       Impact factor: 5.532

  4 in total
  40 in total

1.  Recovery from pulmonary hypertension in an adolescent with mixed connective tissue disease.

Authors:  D M Friedman; H J Mitnick; D Danilowicz
Journal:  Ann Rheum Dis       Date:  1992-08       Impact factor: 19.103

Review 2.  Pulmonary hypertension, antiphospholipid antibodies, and syndromes.

Authors:  Ronald A Asherson; Ricard Cervera
Journal:  Clin Rev Allergy Immunol       Date:  2007-04       Impact factor: 8.667

3.  Preserved action of a rectus muscle after transection by an encircling solid silicone band.

Authors:  I Ashkenazi; J Moisseiev; E Bartov; G Treister
Journal:  Br J Ophthalmol       Date:  1991-08       Impact factor: 4.638

4.  Laryngeal involvement as a presenting symptom of systemic lupus erythematosus.

Authors:  A Kraus; G Guerra-Bautista
Journal:  Ann Rheum Dis       Date:  1990-06       Impact factor: 19.103

Review 5.  Antiphospholipid antibody syndrome: a review.

Authors:  P J Bingley; B I Hoffbrand
Journal:  J R Soc Med       Date:  1987-07       Impact factor: 5.344

Review 6.  Imaging of cardiovascular complications in patients with systemic lupus erythematosus.

Authors:  K Lin; D M Lloyd-Jones; D Li; Y Liu; J Yang; M Markl; J C Carr
Journal:  Lupus       Date:  2015-06-02       Impact factor: 2.911

7.  Circulating lupus type anticoagulant and pulmonary hypertension associated with mixed connective tissue disease.

Authors:  P Hainaut; E Lavenne; J M Magy; E G Lebacq
Journal:  Clin Rheumatol       Date:  1986-01       Impact factor: 2.980

8.  The lupus anticoagulant, pulmonary thromboembolism, and fatal pulmonary hypertension.

Authors:  N E Anderson; M R Ali
Journal:  Ann Rheum Dis       Date:  1984-10       Impact factor: 19.103

9.  Current understanding of systemic lupus erythematosus.

Authors:  G R Hughes
Journal:  Inflammation       Date:  1984-06       Impact factor: 4.092

10.  Primary pulmonary hypertension associated with systemic lupus erythematosus.

Authors:  A Turner; A Samanta; F E Nichol
Journal:  Clin Rheumatol       Date:  1991-09       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.